Publications by authors named "Rom Paz"

Claim this Profile
C
Cancer Cell Permeability Induced by Tumor Treating Fields (TTFields) as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance.
Bella Koltun, Tali Voloshin, Cfir David, Tal Kan, Yiftah Barsheshet, Rom Paz

Mol Cancer Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields).
Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, Rom Paz, Lina Somri-Gannam

Cell Death Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.
Yiftah Barsheshet, Tali Voloshin, Boris Brant, Gadi Cohen, Lilach Koren, Rom Paz

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics.
Tali Voloshin, Rosa Sara Schneiderman, Alexandra Volodin, Reuben Ruby Shamir, Noa Kaynan, Rom Paz

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways.
Limor Avrahami, Rom Paz, Kristina Dominko, Silva Hecimovic, Cecilia Bucci

Cell Signal· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique type of GSK-3 inhibitor brings new opportunities to the clinic.
Avital Licht-Murava, Rom Paz, Lilach Vaks, Limor Avrahami, Batya Plotkin

Sci Signal· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis